Breast Cancer
Metastatic Right Breast Carcinoma
Female, 46 years
Patient Internal ID: 183594467
ICD-10 code
C50.8 Malignant Neoplasm of Overlapping Lesions of Breast
Diagnosis (Incl. Metastases/Stage) and Year
June 2016
Breast Cancer (Right Side) pT2N1miM1 ER (-), PR (-), HER2 (-) (triple-negative) Poorly Differentiated (G3) Metastasis in Hepatis. May 2020 – Metastasis in Bone.
Previous Treatment
Surgery – Quadrantectomy of the Right Breast. Chemotherapy (Docetaxel and Doxorubicin), Chemotherapy (Paclitaxel), Chemotherapy (Nab-paclitaxel), Immunotherapy (Atezolizumab), Chemotherapy (Abemaciclib), Radiation Therapy.
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of 13.3 months from diagnosis.
Treatment Provided
Autologous DCV (10 doses) and CIK (6 doses) over a period of 52 months.
Patient Survival/Condition and Year
Date of Review: 31/01/2024
The patient has survived for 90 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy, Surgery and Radiation Therapy has extended patient survival by an estimate of around 77 months and greatly contributed to disease control.
